BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25127324)

  • 21. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
    Zeamari S; Floot B; van der Vange N; Stewart FA
    Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study.
    Kurreck A; Gronau F; Alberto Vilchez ME; Abels W; Enghard P; Brandl A; Francis R; Föhre B; Lojewski C; Pratschke J; Thuss-Patience P; Modest D; Rau B; Feldbrügge L
    Ann Surg Oncol; 2022 Jan; 29(1):152-162. PubMed ID: 34350529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs.
    Otto WC; Brown RD; Gage-White L; Kupetz S; Anniko M; Penny JE; Henley CM
    Hear Res; 1988 Sep; 35(1):79-85. PubMed ID: 3182412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].
    Schmidt CM; Bartholomäus E; Deuster D; Heinecke A; Dinnesen AG
    HNO; 2007 Apr; 55(4):299-306. PubMed ID: 16437215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ototoxicity of cisplatin in children with malignant diseases].
    Hadjilaskari P; Fengler R; Hartmann R; Henze G
    Klin Padiatr; 1989; 201(4):316-21. PubMed ID: 2779137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.
    D'Hondt V; Goffin F; Roca L; Dresse D; Leroy C; Kerger J; Cordier L; de Forges H; Veys I; Liberale G
    Int J Gynecol Cancer; 2016 Jun; 26(5):912-7. PubMed ID: 27051055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.
    Dille MF; Ellingson RM; McMillan GP; Konrad-Martin D
    J Am Acad Audiol; 2013 Oct; 24(9):769-81. PubMed ID: 24224985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.
    Freyer DR; Brock PR; Chang KW; Dupuis LL; Epelman S; Knight K; Mills D; Phillips R; Potter E; Risby D; Simpkin P; Sullivan M; Cabral S; Robinson PD; Sung L
    Lancet Child Adolesc Health; 2020 Feb; 4(2):141-150. PubMed ID: 31866182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ
    Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
    Crabb SJ; Martin K; Abab J; Ratcliffe I; Thornton R; Lineton B; Ellis M; Moody R; Stanton L; Galanopoulou A; Maishman T; Geldart T; Bayne M; Davies J; Lamb C; Popat S; Joffe JK; Nutting C; Chester J; Hartley A; Thomas G; Ottensmeier C; Huddart R; King E
    Eur J Cancer; 2017 Dec; 87():75-83. PubMed ID: 29128692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular tachycardia during hyperthermic intraperitoneal chemotherapy.
    Thix CA; Königsrainer I; Kind R; Wied P; Schroeder TH
    Anaesthesia; 2009 Oct; 64(10):1134-6. PubMed ID: 19735407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cisplatin ototoxicity. A clinical study].
    Schröder M; Laskawi R; Stennert E; Kühnle H; Thiele FW
    Laryngol Rhinol Otol (Stuttg); 1986 Feb; 65(2):86-9. PubMed ID: 3959692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
    Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Onset of Intra-Abdominal Adhesions During Closed-Abdomen Hyperthermic Intraperitoneal Chemotherapy.
    Lotti M; Giulii Capponi M; Campanati L; Poiasina E; Ansaloni L; Poletti E; Frigerio L
    J Laparoendosc Adv Surg Tech A; 2016 Dec; 26(12):997-1002. PubMed ID: 27705085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.
    Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
    BMC Cancer; 2021 Jul; 21(1):822. PubMed ID: 34271863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: A retrospective cohort study.
    Ye J; Ren Y; Wei Z; Peng J; Chen C; Song W; Tan M; He Y; Yuan Y
    Surg Oncol; 2018 Sep; 27(3):456-461. PubMed ID: 30217302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
    Paken J; Govender CD; Pillay M; Feyasa M; Sewram V
    PLoS One; 2023; 18(4):e0283639. PubMed ID: 37014872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.